Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New chalcone-sulfonamide hybrids exhibiting anticancer and antituberculosis activity
Lina Fernanda Castaño, Viviana Cuartas, Anthony Bernal, et al.
European Journal of Medicinal Chemistry (2019) Vol. 176, pp. 50-60
Closed Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Anticancer Activity of Natural and Synthetic Chalcones
Teodora Constantinescu, Claudiu N. Lungu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11306-11306
Open Access | Times Cited: 121
Pharmacotherapeutics Applications and Chemistry of Chalcone Derivatives
Jagjit Singh Dhaliwal, Said Moshawih, Khang Wen Goh, et al.
Molecules (2022) Vol. 27, Iss. 20, pp. 7062-7062
Open Access | Times Cited: 73
A review on ‘sulfonamides’: their chemistry and pharmacological potentials for designing therapeutic drugs in medical science
Wardha Zafar, Sajjad Hussain Sumrra, Abrar U. Hassan, et al.
Journal of Coordination Chemistry (2023) Vol. 76, Iss. 5-6, pp. 546-580
Closed Access | Times Cited: 47
Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure‐activity relationship
Feng Gao, Gang Huang, Jiaqi Xiao
Medicinal Research Reviews (2020) Vol. 40, Iss. 5, pp. 2049-2084
Closed Access | Times Cited: 107
1,2,3-Triazole-Chalcone hybrids: Synthesis, in vitro cytotoxic activity and mechanistic investigation of apoptosis induction in multiple myeloma RPMI-8226
Heba F. Ashour, Laila Abou‐Zeid, Magda A.‐A. El‐Sayed, et al.
European Journal of Medicinal Chemistry (2020) Vol. 189, pp. 112062-112062
Closed Access | Times Cited: 70
Coumarin hybrid derivatives as promising leads to treat tuberculosis: Recent developments and critical aspects of structural design to exhibit anti-tubercular activity
Dinesh S. Reddy, Manasa Kongot, Amit Kumar
Tuberculosis (2021) Vol. 127, pp. 102050-102050
Closed Access | Times Cited: 63
Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors
Moataz A. Shaldam, Hadia Almahli, Andrea Angeli, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 33
Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: Synthesis, biological assessment, and molecular dynamic simulations
Moataz A. Shaldam, Maha-Hamadien Abdulla, Andrea Angeli, et al.
Journal of Molecular Structure (2024) Vol. 1309, pp. 138148-138148
Closed Access | Times Cited: 8
Design, Synthesis and Molecular Docking Study of Novel 1,3,5-Triazine and 2-Phenylquinazoline Derivatives as Promising Anticancer Agents
M AbdelKarim, Mohammad A. Elmorsy, Khalid B. Selim, et al.
Polycyclic aromatic compounds (2025), pp. 1-35
Closed Access | Times Cited: 1
Recent investigations into synthesis and pharmacological activities of phenoxy acetamide and its derivatives (chalcone, indole and quinoline) as possible therapeutic candidates
Fares Hezam Al-Ostoot, Zabiulla Zabiulla, Salma Salah, et al.
Journal of the Iranian Chemical Society (2021) Vol. 18, Iss. 8, pp. 1839-1875
Open Access | Times Cited: 44
Click reaction inspired synthesis, antimicrobial evaluation and in silico docking of some pyrrole-chalcone linked 1,2,3-triazole hybrids
Monika Yadav, Kashmiri Lal, Aman Kumar, et al.
Journal of Molecular Structure (2022) Vol. 1273, pp. 134321-134321
Closed Access | Times Cited: 29
Terminators or Guardians? Design, Synthesis, and Cytotoxicity Profiling of Chalcone-Sulfonamide Hybrids
Shaimaa M. Aboukhatwa, Peter A. Sidhom, Andrea Angeli, et al.
ACS Omega (2023) Vol. 8, Iss. 8, pp. 7666-7683
Open Access | Times Cited: 19
A minireview of 1,2,3‐triazole hybrids with O‐heterocycles as leads in medicinal chemistry
Bhavna Saroha, Gourav Kumar, Ramesh Kumar, et al.
Chemical Biology & Drug Design (2021) Vol. 100, Iss. 6, pp. 843-869
Closed Access | Times Cited: 39
Synthesis, anticancer evaluation and molecular docking studies of new heterocycles linked to sulfonamide moiety as novel human topoisomerase types I and II poisons
Ahmed H. Halawa, Walid E. Elgammal, Saber M. Hassan, et al.
Bioorganic Chemistry (2020) Vol. 98, pp. 103725-103725
Closed Access | Times Cited: 37
Synthesis and in silico studies of triazene‐substituted sulfamerazine derivatives as acetylcholinesterase and carbonic anhydrases inhibitors
Sinan Bilginer, Halise İnci Gül, Barış Anıl, et al.
Archiv der Pharmazie (2020) Vol. 354, Iss. 1
Closed Access | Times Cited: 35
Biological Role of Chalcones in Medicinal Chemistry
Sunil U. Tekale, Samson S. Mashele, Ofentse Jacob Pooe, et al.
IntechOpen eBooks (2020)
Open Access | Times Cited: 34
DFT, molecular docking and SERS (concentration and solvent dependant) investigations of a methylisoxazole derivative with potential antimicrobial activity
Y. Sheena Mary, Y. Sheena Mary, Martin Krátký, et al.
Journal of Molecular Structure (2021) Vol. 1232, pp. 130034-130034
Closed Access | Times Cited: 28
Design, synthesis, and biological evaluation of chalcones for anticancer properties targeting glycogen synthase kinase 3 beta
Seunghyun Ahn, Vi Nguyen-Phuong Truong, Beomsoo Kim, et al.
Applied Biological Chemistry (2022) Vol. 65, Iss. 1
Open Access | Times Cited: 20
Recent Advances in Biological Active Sulfonamide based Hybrid Compounds Part A: Two-Component Sulfonamide Hybrids
Reihane Ghomashi, Shakila Ghomashi, Hamidreza Aghaei, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 4, pp. 407-480
Closed Access | Times Cited: 20
Excavating medicinal virtues of chalcones to illuminate a new scope in cancer chemotherapy
T. Nivedya, Nilmadhab Roy, Priyankar Paira, et al.
RSC Advances (2025) Vol. 15, Iss. 15, pp. 11617-11638
Open Access
A novel chalcone derivative as Nrf2 activator attenuates learning and memory impairment in a scopolamine-induced mouse model
Hyeon Jeong Kim, Bo Ko Jang, Jong‐Hyun Park, et al.
European Journal of Medicinal Chemistry (2019) Vol. 185, pp. 111777-111777
Closed Access | Times Cited: 31
<p>Novel HDAC/Tubulin Dual Inhibitor: Design, Synthesis and Docking Studies of α-Phthalimido-Chalcone Hybrids as Potential Anticancer Agents with Apoptosis-Inducing Activity</p>
Ahmed A.E. Mourad, Mai A.E. Mourad, Peter G. Jones
Drug Design Development and Therapy (2020) Vol. Volume 14, pp. 3111-3130
Open Access | Times Cited: 31
Design, synthesis, in silico studies, and evaluation of novel chalcones and their pyrazoline derivatives for antibacterial and antitubercular activities
Shivani Pola, Banoth Karan Kumar, Sankaranarayanan Murugesan, et al.
Medicinal Chemistry Research (2020) Vol. 29, Iss. 10, pp. 1819-1835
Closed Access | Times Cited: 28
A novel statistical approach for the synthesis of Chalcones viaClaisen-Schmidt condensation catalyzed by Pd nanoparticles modified mesoporous TiO2 as an efficient heterogeneous catalyst
Hanane Chaker, Ghaniya Ferouani, Ilyas Chikhi, et al.
Colloids and Interface Science Communications (2021) Vol. 43, pp. 100461-100461
Closed Access | Times Cited: 26
One‐potandtwo‐potmethods for chalcone derived pyrimidines synthesis and applications
Saba Farooq, Zainab Ngaini
Journal of Heterocyclic Chemistry (2021) Vol. 58, Iss. 6, pp. 1209-1224
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top